MetaADEDB 2.0 @ LMMD
Epoprostenol
(LMHIPJMTZHDKEW-XQYLJSSYSA-M)
Structure
SMILES
CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O.[Na+]
Molecular Formula:
C20H31NaO5
Molecular Weight:
374.447
Log P:
2.0738
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
89.82
CAS Number(s):
61849-14-7
Synonym(s)
1.
Epoprostenol
2.
Prostacyclin
3.
Prostaglandin I2
4.
Epoprostanol
5.
Epoprostenol Sodium
6.
Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer
7.
Flolan
8.
Prostaglandin I(2)
9.
Veletri
External Link(s)
MeSHD011464
PubChem Compound6364626
CHEMBLCHEMBL962
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 232US FAERS
2HeadacheFAERS: 231US FAERS
3PneumoniaFAERS: 152US FAERS
4FlushingFAERS: 120US FAERS
5VomitingFAERS: 119US FAERS
6MalaiseFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Device related infectionFAERS: 109US FAERS
8Pulmonary arterial hypertensionFAERS: 107
Canada Vigilance: 1
Canada Vigilance
US FAERS
9DizzinessFAERS: 85US FAERS
10Catheter site erythemaFAERS: 81US FAERS
11Chest PainFAERS: 80US FAERS
12FatigueFAERS: 80US FAERS
13HypotensionFAERS: 80
Canada Vigilance: 1
Canada Vigilance
US FAERS
14AstheniaFAERS: 77US FAERS
15PainFAERS: 70US FAERS
16AscitesFAERS: 65US FAERS
17Right ventricular failureFAERS: 59
Canada Vigilance: 1
Canada Vigilance
US FAERS
18Abdominal PainFAERS: 55US FAERS
19SepsisFAERS: 54US FAERS
20Catheter site painFAERS: 53US FAERS
21Pulmonary HypertensionFAERS: 53US FAERS
22Catheter managementFAERS: 51US FAERS
23NasopharyngitisFAERS: 51US FAERS
24Weight decreasedFAERS: 48US FAERS
25Catheter site pruritusFAERS: 47US FAERS
26PalpitationsFAERS: 46US FAERS
27Back PainFAERS: 45US FAERS
28DehydrationFAERS: 45US FAERS
29Disease ProgressionFAERS: 45
Canada Vigilance: 3
Canada Vigilance
US FAERS
30Medical device complicationFAERS: 45US FAERS
31Fluid overloadFAERS: 43US FAERS
32InfectionFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
33ArthralgiaFAERS: 41US FAERS
34HypoxiaFAERS: 41US FAERS
35Catheter site infectionFAERS: 39US FAERS
36SyncopeFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
37ErythemaFAERS: 37US FAERS
38Catheter placementFAERS: 36US FAERS
39Device leakageFAERS: 36US FAERS
40Feeling abnormalFAERS: 34US FAERS
41Urinary tract infectionFAERS: 34US FAERS
42Drug dose omissionFAERS: 33US FAERS
43Device infusion issueFAERS: 32US FAERS
44Device occlusionFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Device dislocationFAERS: 31US FAERS
46HyperthyroidismFAERS: 31US FAERS
47SwellingFAERS: 31US FAERS
48Drug administration errorFAERS: 30US FAERS
49SinusitisFAERS: 30US FAERS
50Device breakageFAERS: 29US FAERS
51Catheter site dischargeFAERS: 28US FAERS
52Catheter site swellingFAERS: 28US FAERS
53CellulitisFAERS: 28US FAERS
54EpistaxisFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Abdominal discomfortFAERS: 26US FAERS
56Atrial FibrillationFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Musculoskeletal PainFAERS: 25US FAERS
58Pharmaceutical product complaintFAERS: 25US FAERS
59TachycardiaFAERS: 25US FAERS
60Respiratory FailureFAERS: 24US FAERS
61ThrombocytopeniaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Adverse eventFAERS: 23US FAERS
63Cardiac ArrestFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
64Peripheral swellingFAERS: 23US FAERS
65ConstipationFAERS: 22US FAERS
66Therapy cessationFAERS: 22US FAERS
67AnxietyFAERS: 21US FAERS
68BronchitisFAERS: 21US FAERS
69Complication associated with deviceFAERS: 21US FAERS
70Catheter site inflammationFAERS: 20US FAERS
71Mental status changesFAERS: 20US FAERS
72Chest discomfortFAERS: 19US FAERS
73ChillsFAERS: 19US FAERS
74Device alarm issueFAERS: 19US FAERS
75PruritusFAERS: 19US FAERS
76Device malfunctionFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
77Incorrect route of drug administrationFAERS: 18US FAERS
78InfluenzaFAERS: 18US FAERS
79AlopeciaFAERS: 16US FAERS
80MyalgiaFAERS: 16US FAERS
81PancytopeniaFAERS: 15US FAERS
82ParacentesisFAERS: 15US FAERS
83Product use issueFAERS: 15US FAERS
84Pulmonary arterial pressure increasedFAERS: 15US FAERS
85Respiratory distressFAERS: 15US FAERS
86Bone painFAERS: 14US FAERS
87Catheter related complicationFAERS: 14US FAERS
88Clostridium difficile infectionFAERS: 14US FAERS
89Device damageFAERS: 14US FAERS
90Incorrect route of product administrationFAERS: 14US FAERS
91Thrombosis in deviceFAERS: 14US FAERS
92Blood count abnormalFAERS: 13US FAERS
93Cerebrovascular accidentFAERS: 13US FAERS
94Limb discomfortFAERS: 13US FAERS
95PneumothoraxFAERS: 13US FAERS
96Product quality issueFAERS: 13US FAERS
97ThrombosisFAERS: 13US FAERS
98DysgeusiaFAERS: 12US FAERS
99EosinophiliaFAERS: 12US FAERS
100Infusion site erythemaFAERS: 12US FAERS
101Septic ShockFAERS: 12US FAERS
102TransplantFAERS: 12US FAERS
103TremorFAERS: 12US FAERS
104Acute kidney injuryFAERS: 11US FAERS
105Burning sensationFAERS: 11US FAERS
106Catheter site rashFAERS: 11US FAERS
107Central venous catheter removalFAERS: 11US FAERS
108Neck PainFAERS: 11US FAERS
109OverdoseFAERS: 11US FAERS
110PancreatitisFAERS: 11US FAERS
111Pericardial effusionFAERS: 11US FAERS
112Unevaluable eventFAERS: 11US FAERS
113WheezingFAERS: 11US FAERS
114Drug ineffectiveFAERS: 10US FAERS
115General physical health deteriorationFAERS: 10US FAERS
116Pulmonary EmbolismFAERS: 10US FAERS
117Skin irritationFAERS: 10US FAERS
118SplenomegalyFAERS: 10US FAERS
119Blood potassium decreasedFAERS: 9US FAERS
120Catheter site vesiclesFAERS: 9US FAERS
121Medication ErrorFAERS: 9US FAERS
122Night sweatsFAERS: 9US FAERS
123Oxygen consumption increasedFAERS: 9US FAERS
124PallorFAERS: 9US FAERS
125ShockFAERS: 9US FAERS
126SomnolenceFAERS: 9US FAERS
127UrticariaFAERS: 9US FAERS
128Dry skinFAERS: 8US FAERS
129GoutFAERS: 8US FAERS
130Infusion site painFAERS: 8US FAERS
131LethargyFAERS: 8US FAERS
132MalnutritionFAERS: 8US FAERS
133Memory impairmentFAERS: 8US FAERS
134Myocardial InfarctionFAERS: 8US FAERS
135NervousnessFAERS: 8US FAERS
136Product depositFAERS: 8US FAERS
137Product preparation errorFAERS: 8US FAERS
138Productive CoughFAERS: 8US FAERS
139Ammonia increasedFAERS: 7US FAERS
140Application site pruritusFAERS: 7US FAERS
141CataractFAERS: 7US FAERS
142DeliriumFAERS: 7US FAERS
143Device connection issueFAERS: 7US FAERS
144Device use errorFAERS: 7US FAERS
145DyspepsiaFAERS: 7US FAERS
146Infusion site infectionFAERS: 7US FAERS
147Joint swellingFAERS: 7US FAERS
148Lower respiratory tract infectionFAERS: 7US FAERS
149NephrolithiasisFAERS: 7US FAERS
150PregnancyFAERS: 7US FAERS
151Rash erythematousFAERS: 7US FAERS
152Respiratory arrestFAERS: 7US FAERS
153RetchingFAERS: 7US FAERS
154Unresponsive to stimuliFAERS: 7US FAERS
155Application site erythemaFAERS: 6US FAERS
156AsthmaFAERS: 6US FAERS
157Blood iron decreasedFAERS: 6US FAERS
158Blood sodium decreasedFAERS: 6US FAERS
159CardiomegalyFAERS: 6US FAERS
160Catheter site related reactionFAERS: 6US FAERS
161Concomitant disease aggravatedFAERS: 6US FAERS
162Diabetes MellitusFAERS: 6US FAERS
163Disease complicationFAERS: 6US FAERS
164DysenteryFAERS: 6US FAERS
165Gastric infectionFAERS: 6US FAERS
166HypersensitivityFAERS: 6US FAERS
167HypersplenismFAERS: 6US FAERS
168Infusion site pruritusFAERS: 6US FAERS
169Platelet TransfusionFAERS: 6US FAERS
170Post procedural complicationFAERS: 6US FAERS
171Skin UlcerFAERS: 6US FAERS
172Sudden deathFAERS: 6US FAERS
173Therapy changeFAERS: 6US FAERS
174AnuriaFAERS: 5US FAERS
175Application site rashFAERS: 5US FAERS
176Blood glucose decreasedFAERS: 5US FAERS
177Blood thyroid stimulating hormone decreasedFAERS: 5US FAERS
178Catheter site scabFAERS: 5US FAERS
179CyanosisFAERS: 5US FAERS
180CystitisFAERS: 5US FAERS
181Drug administered to patient of inappropriate ageFAERS: 5US FAERS
182Emergency CareFAERS: 5US FAERS
183Gait inabilityFAERS: 5US FAERS
184Gastrointestinal infectionFAERS: 5US FAERS
185HypopituitarismFAERS: 5US FAERS
186HypothyroidismFAERS: 5US FAERS
187Incorrect dose administeredFAERS: 5US FAERS
188InflammationFAERS: 5US FAERS
189Infusion site swellingFAERS: 5US FAERS
190Live BirthFAERS: 5US FAERS
191Loss of personal independence in daily activitiesFAERS: 5US FAERS
192LymphadenopathyFAERS: 5US FAERS
193Maternal exposure during pregnancyFAERS: 5US FAERS
194Medical device changeFAERS: 5US FAERS
195Micrococcus infectionFAERS: 5US FAERS
196Muscle strainFAERS: 5US FAERS
197Muscle tightnessFAERS: 5US FAERS
198PresyncopeFAERS: 5US FAERS
199Procedural complicationFAERS: 5US FAERS
200Product use in unapproved indicationFAERS: 5US FAERS
201SclerodermaFAERS: 5US FAERS
202Skin reactionFAERS: 5US FAERS
203Supraventricular tachycardiaFAERS: 5US FAERS
204Therapeutic procedureFAERS: 5US FAERS
205Throat irritationFAERS: 5US FAERS
206ThyroiditisFAERS: 5US FAERS
207Tooth InfectionFAERS: 5US FAERS
208Vascular device infectionFAERS: 5US FAERS
209White blood cell count decreasedFAERS: 5US FAERS
210AmnesiaFAERS: 4US FAERS
211Angina PectorisFAERS: 4US FAERS
212Application site dischargeFAERS: 4US FAERS
213Application site hypersensitivityFAERS: 4US FAERS
214AtelectasisFAERS: 4US FAERS
215Blood glucose increasedFAERS: 4US FAERS
216Blood pressure fluctuationFAERS: 4US FAERS
217Bowel movement irregularityFAERS: 4US FAERS
218Cardiac ablationFAERS: 4US FAERS
219Cataract operationFAERS: 4US FAERS
220Catheter site cellulitisFAERS: 4US FAERS
221Catheter site dermatitisFAERS: 4US FAERS
222Catheter site irritationFAERS: 4US FAERS
223ChemotherapyFAERS: 4US FAERS
224CryingFAERS: 4US FAERS
225CystFAERS: 4US FAERS
226Deep Vein ThrombosisFAERS: 4US FAERS
227Device FailureFAERS: 4US FAERS
228DiscomfortFAERS: 4US FAERS
229Drug exposure during pregnancyFAERS: 4US FAERS
230Ear discomfortFAERS: 4US FAERS
231Electrolyte imbalanceFAERS: 4US FAERS
232EmbolismFAERS: 4US FAERS
233Eye InfectionFAERS: 4US FAERS
234Eye irritationFAERS: 4US FAERS
235Eye painFAERS: 4US FAERS
236Hepatic InfectionFAERS: 4US FAERS
237IncoherentFAERS: 4US FAERS
238Intentional device misuseFAERS: 4US FAERS
239LacerationFAERS: 4US FAERS
240Leukocytoclastic vasculitisFAERS: 4US FAERS
241Liver transplant rejectionFAERS: 4US FAERS
242Oxygen saturation abnormalFAERS: 4US FAERS
243Pain managementFAERS: 4US FAERS
244PapuleFAERS: 4US FAERS
245PharyngitisFAERS: 4US FAERS
246PhotophobiaFAERS: 4US FAERS
247PolyuriaFAERS: 4US FAERS
248Pulmonary endarterectomyFAERS: 4US FAERS
249RhinalgiaFAERS: 4US FAERS
250Secretion dischargeFAERS: 4US FAERS
251Suicide attemptFAERS: 4US FAERS
252Terminal stateFAERS: 4US FAERS
253Therapeutic response unexpectedFAERS: 4US FAERS
254ThyroidectomyFAERS: 4US FAERS
255Urinary IncontinenceFAERS: 4US FAERS
256Abdominal cavity drainageFAERS: 3US FAERS
257Accidental overdoseFAERS: 3US FAERS
258Acute respiratory failureFAERS: 3US FAERS
259Application site irritationFAERS: 3US FAERS
260Application site reactionFAERS: 3US FAERS
261Atrial FlutterFAERS: 3US FAERS
262Blister ruptureFAERS: 3US FAERS
263Blood chloride increasedFAERS: 3US FAERS
264Blood glucose fluctuationFAERS: 3US FAERS
265Blood sodium abnormalFAERS: 3US FAERS
266Blood urine presentFAERS: 3US FAERS
267BradycardiaFAERS: 3US FAERS
268Brain natriuretic peptide increasedFAERS: 3US FAERS
269Catheter related infectionFAERS: 3US FAERS
270Central line infectionFAERS: 3US FAERS
271CholecystitisFAERS: 3US FAERS
272CholelithiasisFAERS: 3US FAERS
273DeafnessFAERS: 3US FAERS
274DementiaFAERS: 3US FAERS
275Depressed Level of ConsciousnessFAERS: 3US FAERS
276DermatitisFAERS: 3US FAERS
277Device component issueFAERS: 3US FAERS
278Device defectiveFAERS: 3US FAERS
279DisorientationFAERS: 3US FAERS
280DiverticulitisFAERS: 3US FAERS
281DroolingFAERS: 3US FAERS
282Drug titration errorFAERS: 3US FAERS
283EczemaFAERS: 3US FAERS
284Emergency care examinationFAERS: 3US FAERS
285EndocarditisFAERS: 3US FAERS
286Extracorporeal Membrane OxygenationFAERS: 3US FAERS
287First bite syndromeFAERS: 3US FAERS
288FlatulenceFAERS: 3US FAERS
289Food PoisoningFAERS: 3US FAERS
290HerniaFAERS: 3US FAERS
291Hip surgeryFAERS: 3US FAERS
292HypercapniaFAERS: 3US FAERS
293Incorrect dose administered by deviceFAERS: 3US FAERS
294Infusion Site ExtravasationFAERS: 3US FAERS
295Injection site vesiclesFAERS: 3US FAERS
296Livedo ReticularisFAERS: 3US FAERS
297Oropharyngeal painFAERS: 3US FAERS
298Product dose omissionFAERS: 3US FAERS
299Pulmonary congestionFAERS: 3US FAERS
300Pulmonary vein occlusionFAERS: 3US FAERS
301ScabFAERS: 3US FAERS
302Serratia sepsisFAERS: 3US FAERS
303Silent thyroiditisFAERS: 3US FAERS
304SneezingFAERS: 3US FAERS
305Staphylococcus test positiveFAERS: 3US FAERS
306StomatitisFAERS: 3US FAERS
307Therapy non-responderFAERS: 3US FAERS
308Thyroid stimulating immunoglobulin increasedFAERS: 3US FAERS
309TinnitusFAERS: 3US FAERS
310Upper-airway cough syndromeFAERS: 3US FAERS
311AbscessFAERS: 2US FAERS
312Accidental exposure to productFAERS: 2US FAERS
313Activities of daily living impairedFAERS: 2US FAERS
314AgranulocytosisFAERS: 2US FAERS
315AngioplastyFAERS: 2US FAERS
316AphoniaFAERS: 2US FAERS
317AppendicitisFAERS: 2US FAERS
318Application site inflammationFAERS: 2US FAERS
319ArthritisFAERS: 2US FAERS
320Bladder NeoplasmFAERS: 2US FAERS
321Blood creatine phosphokinase increasedFAERS: 2US FAERS
322Blood electrolytes decreasedFAERS: 2US FAERS
323Blood magnesium abnormalFAERS: 2US FAERS
324Blood magnesium decreasedFAERS: 2US FAERS
325BronchospasmFAERS: 2US FAERS
326CachexiaFAERS: 2US FAERS
327Cardiac valve vegetationFAERS: 2US FAERS
328Catheter culture positiveFAERS: 2US FAERS
329Catheter site injuryFAERS: 2US FAERS
330Cerebral InfarctionFAERS: 2US FAERS
331CholangitisFAERS: 2US FAERS
332ChromaturiaFAERS: 2US FAERS
333Chronic respiratory failureFAERS: 2US FAERS
334Clostridium test positiveFAERS: 2US FAERS
335ColitisFAERS: 2US FAERS
336Concomitant disease progressionFAERS: 2US FAERS
337Cor pulmonaleFAERS: 2US FAERS
338Croup infectiousFAERS: 2US FAERS
339Depressed moodFAERS: 2US FAERS
340Device related thrombosisFAERS: 2US FAERS
341Disease recurrenceFAERS: 2US FAERS
342EndarterectomyFAERS: 2US FAERS
343Endoscopic Retrograde CholangiopancreatographyFAERS: 2US FAERS
344Escherichia infectionFAERS: 2US FAERS
345Exposure via skin contactFAERS: 2US FAERS
346ExtravasationFAERS: 2US FAERS
347Feeling ColdFAERS: 2US FAERS
348GastritisFAERS: 2US FAERS
349Gastroenteritis norovirusFAERS: 2US FAERS
350GastroenteritisFAERS: 2US FAERS
351General physical condition abnormalFAERS: 2US FAERS
352HemiparesisFAERS: 2US FAERS
353HepatitisFAERS: 2US FAERS
354HepatomegalyFAERS: 2US FAERS
355Hospice CareFAERS: 2US FAERS
356Incorrect drug administration rateFAERS: 2US FAERS
357Incorrect product storageFAERS: 2US FAERS
358Infusion site rashFAERS: 2US FAERS
359Infusion site warmthFAERS: 2US FAERS
360Injection site painFAERS: 2US FAERS
361Irritable Bowel SyndromeFAERS: 2US FAERS
362Joint injuryFAERS: 2US FAERS
363Joint stiffnessFAERS: 2US FAERS
364LeukocytosisFAERS: 2US FAERS
365Limb injuryFAERS: 2US FAERS
366Macular degenerationFAERS: 2US FAERS
367MastectomyFAERS: 2US FAERS
368Mechanical ventilationFAERS: 2US FAERS
369Micrococcal sepsisFAERS: 2US FAERS
370Multiple SclerosisFAERS: 2US FAERS
371Multiple allergiesFAERS: 2US FAERS
372Myocardial necrosis marker increasedFAERS: 2US FAERS
373NeuralgiaFAERS: 2US FAERS
374NeutropeniaFAERS: 2US FAERS
375OsteomyelitisFAERS: 2US FAERS
376Pain of skinFAERS: 2US FAERS
377Palliative CareFAERS: 2US FAERS
378Palpable purpuraFAERS: 2US FAERS
379Paranasal sinus discomfortFAERS: 2US FAERS
380PeritonitisFAERS: 2US FAERS
381PleurisyFAERS: 2US FAERS
382Portal HypertensionFAERS: 2US FAERS
383Portal hypertensive gastropathyFAERS: 2US FAERS
384Procedural hypotensionFAERS: 2US FAERS
385Pseudomonas test positiveFAERS: 2US FAERS
386PsoriasisFAERS: 2US FAERS
387Rectal ProlapseFAERS: 2US FAERS
388Sinus headacheFAERS: 2US FAERS
389Skin weepingFAERS: 2US FAERS
390Sleep TalkingFAERS: 2US FAERS
391Slow speechFAERS: 2US FAERS
392Tooth ExtractionFAERS: 2US FAERS
393Transplant evaluationFAERS: 2US FAERS
394Troponin increasedFAERS: 2US FAERS
395Vascular occlusionFAERS: 2US FAERS
396Venous ThrombosisFAERS: 2US FAERS
397Visual ImpairmentFAERS: 2US FAERS
398Walking distance test abnormalFAERS: 2US FAERS
399Wound InfectionFAERS: 2US FAERS
400Wrong technique in product usage processFAERS: 2US FAERS
401colonoscopyFAERS: 2US FAERS
402Abdominal tendernessFAERS: 1US FAERS
403AcanthosisFAERS: 1US FAERS
404AcidosisFAERS: 1US FAERS
405Acute right ventricular failureFAERS: 1US FAERS
406Administration site cellulitisFAERS: 1US FAERS
407Administration site pruritusFAERS: 1US FAERS
408AgeusiaFAERS: 1US FAERS
409AgitationFAERS: 1US FAERS
410Alanine Aminotransferase IncreasedFAERS: 1US FAERS
411Alcohol rehabilitationFAERS: 1US FAERS
412Alcohol withdrawal syndromeFAERS: 1US FAERS
413Altered state of consciousnessFAERS: 1US FAERS
414Anti-neutrophil cytoplasmic antibody positive vasculitisFAERS: 1US FAERS
415Anti-thyroid antibody positiveFAERS: 1US FAERS
416Antibiotic therapyFAERS: 1US FAERS
417Aphthous StomatitisFAERS: 1US FAERS
418Application site painFAERS: 1US FAERS
419Application site vesiclesFAERS: 1US FAERS
420Arterial thrombosisFAERS: 1US FAERS
421ArteriosclerosisFAERS: 1US FAERS
422ArthropathyFAERS: 1US FAERS
423Arthropod biteFAERS: 1US FAERS
424Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
425Auricular swellingFAERS: 1US FAERS
426Autoimmune hepatitisFAERS: 1US FAERS
427Autoimmune thrombocytopeniaFAERS: 1US FAERS
428Autoimmune thyroiditisFAERS: 1US FAERS
429Bacterial sepsisFAERS: 1US FAERS
430Bacterial test positiveFAERS: 1US FAERS
431Bed restFAERS: 1US FAERS
432Benign neoplasm of scrotumFAERS: 1US FAERS
433Biliary cirrhosisFAERS: 1US FAERS
434Biopsy thyroid gland abnormalFAERS: 1US FAERS
435Bladder neck suspensionFAERS: 1US FAERS
436Blood cortisol decreasedFAERS: 1US FAERS
437Blood creatinine increasedFAERS: 1US FAERS
438Blood glucose abnormalFAERS: 1US FAERS
439Blood immunoglobulin E increasedFAERS: 1US FAERS
440Blood osmolarity decreasedFAERS: 1US FAERS
441Blood potassium increasedFAERS: 1US FAERS
442Bone marrow reticulin fibrosisFAERS: 1US FAERS
443Brain DeathFAERS: 1US FAERS
444Bronchial ObstructionFAERS: 1US FAERS
445BronchopneumoniaFAERS: 1US FAERS
446BronchoscopyFAERS: 1US FAERS
447Butterfly rashFAERS: 1US FAERS
448C-reactive protein decreasedFAERS: 1US FAERS
449Candida test positiveFAERS: 1US FAERS
450Carbon dioxide increasedFAERS: 1US FAERS
451Cardiac OutputFAERS: 1US FAERS
452Cardiac TamponadeFAERS: 1US FAERS
453Cardiovascular insufficiencyFAERS: 1US FAERS
454Catheter sepsisFAERS: 1US FAERS
455Catheter site abscessFAERS: 1US FAERS
456Catheter site extravasationFAERS: 1US FAERS
457Catheter site hypersensitivityFAERS: 1US FAERS
458Catheter site indurationFAERS: 1US FAERS
459Catheter site pustuleFAERS: 1US FAERS
460Catheter site scarFAERS: 1US FAERS
461Catheter site urticariaFAERS: 1US FAERS
462Catheter site warmthFAERS: 1US FAERS
463ChokingFAERS: 1US FAERS
464Clostridium difficile colitisFAERS: 1US FAERS
465Cold sweatFAERS: 1US FAERS
466ColectomyFAERS: 1US FAERS
467Complications of transplant surgeryFAERS: 1US FAERS
468Compression fractureFAERS: 1US FAERS
469Contraceptive implantFAERS: 1US FAERS
470Coronary angioplastyFAERS: 1US FAERS
471Culture positiveFAERS: 1US FAERS
472Culture tissue specimen positiveFAERS: 1US FAERS
473Culture urine positiveFAERS: 1US FAERS
474Cyst removalFAERS: 1US FAERS
475CytologyFAERS: 1US FAERS
476Device adhesion issueFAERS: 1US FAERS
477Device battery issueFAERS: 1US FAERS
478Device deposit issueFAERS: 1US FAERS
479Device related sepsisFAERS: 1US FAERS
480Diabetic KetoacidosisFAERS: 1US FAERS
481Dialysis device insertionFAERS: 1US FAERS
482Dieulafoy's vascular malformationFAERS: 1US FAERS
483Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
484DiplopiaFAERS: 1US FAERS
485Disease risk factorFAERS: 1US FAERS
486Drug DependenceFAERS: 1US FAERS
487Drug dispensing errorFAERS: 1US FAERS
488Drug effect incompleteFAERS: 1US FAERS
489Drug therapy enhancementFAERS: 1US FAERS
490Drug withdrawal syndromeFAERS: 1US FAERS
491Dry gangreneFAERS: 1US FAERS
492DysgraphiaFAERS: 1US FAERS
493DysphoniaFAERS: 1US FAERS
494DysuriaFAERS: 1US FAERS
495Ear congestionFAERS: 1US FAERS
496Echocardiogram abnormalFAERS: 1US FAERS
497Ectopic PregnancyFAERS: 1US FAERS
498Electroencephalogram abnormalFAERS: 1US FAERS
499Electromechanical dissociationFAERS: 1US FAERS
500Endometrial hypertrophyFAERS: 1US FAERS
501Endoscopic retrograde cholangiopancreatography abnormalFAERS: 1US FAERS
502EnterobiasisFAERS: 1US FAERS
503EnterocolitisFAERS: 1US FAERS
504EpididymitisFAERS: 1US FAERS
505Expired product administeredFAERS: 1US FAERS
506Exposure via inhalationFAERS: 1US FAERS
507Eye inflammationFAERS: 1US FAERS
508Facial PainFAERS: 1US FAERS
509Failure to ThriveFAERS: 1US FAERS
510Febrile NeutropeniaFAERS: 1US FAERS
511Feeling jitteryFAERS: 1US FAERS
512FibromyalgiaFAERS: 1US FAERS
513Flank PainFAERS: 1US FAERS
514Frustration tolerance decreasedFAERS: 1US FAERS
515Full blood count abnormalFAERS: 1US FAERS
516GangreneFAERS: 1US FAERS
517Gastrostomy failureFAERS: 1US FAERS
518GastrostomyFAERS: 1US FAERS
519Granulocyte count decreasedFAERS: 1US FAERS
520Guillain-Barre SyndromeFAERS: 1US FAERS
521Hepatic EncephalopathyFAERS: 1US FAERS
522Hepatic congestionFAERS: 1US FAERS
523Hepatorenal SyndromeFAERS: 1US FAERS
524HepatosplenomegalyFAERS: 1US FAERS
525HydronephrosisFAERS: 1US FAERS
526HypersomniaFAERS: 1US FAERS
527HyperventilationFAERS: 1US FAERS
528HypophagiaFAERS: 1US FAERS
529HypophysitisFAERS: 1US FAERS
530HysterectomyFAERS: 1US FAERS
531ImpetigoFAERS: 1US FAERS
532Inappropriate schedule of drug administrationFAERS: 1US FAERS
533Inappropriate schedule of product administrationFAERS: 1US FAERS
534Incision site erythemaFAERS: 1US FAERS
535Incision site inflammationFAERS: 1US FAERS
536Increased upper airway secretionFAERS: 1US FAERS
537Infectious MononucleosisFAERS: 1US FAERS
538Infectious colitisFAERS: 1US FAERS
539Infectious peritonitisFAERS: 1US FAERS
540Infusion site dermatitisFAERS: 1US FAERS
541Infusion site inflammationFAERS: 1US FAERS
542Infusion site reactionFAERS: 1US FAERS
543Injection site dischargeFAERS: 1US FAERS
544Injection site erythemaFAERS: 1US FAERS
545Injection site irritationFAERS: 1US FAERS
546Injection site massFAERS: 1US FAERS
547Insertion of ambulatory peritoneal catheterFAERS: 1US FAERS
548Intentional drug misuseFAERS: 1US FAERS
549Intentional product use issueFAERS: 1US FAERS
550Intentional self-injuryFAERS: 1US FAERS
551Intervertebral disc disorderFAERS: 1US FAERS
552Intestinal ObstructionFAERS: 1US FAERS
553Intestinal PerforationFAERS: 1US FAERS
554Invasive Ductal Breast CarcinomaFAERS: 1US FAERS
555Investigation abnormalFAERS: 1US FAERS
556Joint warmthFAERS: 1US FAERS
557Labile blood pressureFAERS: 1US FAERS
558Large intestinal polypectomyFAERS: 1US FAERS
559Large intestine perforationFAERS: 1US FAERS
560LaryngitisFAERS: 1US FAERS
561LeukopeniaFAERS: 1US FAERS
562Limb operationFAERS: 1US FAERS
563Liquid product physical issueFAERS: 1US FAERS
564Localised intraabdominal fluid collectionFAERS: 1US FAERS
565Low birth weight babyFAERS: 1US FAERS
566Lung InjuryFAERS: 1US FAERS
567Lung consolidationFAERS: 1US FAERS
568Lung transplant rejectionFAERS: 1US FAERS
569Lymphocytic infiltrationFAERS: 1US FAERS
570MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
571Mallory-Weiss SyndromeFAERS: 1US FAERS
572Medical device removalFAERS: 1US FAERS
573Megakaryocytes increasedFAERS: 1US FAERS
574MenorrhagiaFAERS: 1US FAERS
575Metabolic acidosisFAERS: 1US FAERS
576MetastasisFAERS: 1US FAERS
577MiliariaFAERS: 1US FAERS
578Multiple sclerosis relapseFAERS: 1US FAERS
579Musculoskeletal chest painFAERS: 1US FAERS
580Musculoskeletal stiffnessFAERS: 1US FAERS
581MydriasisFAERS: 1US FAERS
582MyelofibrosisFAERS: 1US FAERS
583N-terminal prohormone brain natriuretic peptide increasedFAERS: 1US FAERS
584Nasal discomfortFAERS: 1US FAERS
585NocturiaFAERS: 1US FAERS
586Nonspecific reactionFAERS: 1US FAERS
587ObstructionFAERS: 1US FAERS
588Occupational exposure to productFAERS: 1US FAERS
589OliguriaFAERS: 1US FAERS
590OnychalgiaFAERS: 1US FAERS
591Oral painFAERS: 1US FAERS
592OrchitisFAERS: 1US FAERS
593Otitis MediaFAERS: 1US FAERS
594Oxygen consumption decreasedFAERS: 1US FAERS
595Oxygen supplementationFAERS: 1US FAERS
596PCO2 increasedFAERS: 1US FAERS
597Pancreatic CystFAERS: 1US FAERS
598Pancreatic carcinomaFAERS: 1US FAERS
599ParathyroidectomyFAERS: 1US FAERS
600Parenteral NutritionFAERS: 1US FAERS
601Patent ductus arteriosusFAERS: 1US FAERS
602Pathogen resistanceFAERS: 1US FAERS
603Pelvic massFAERS: 1US FAERS
604PemphigusFAERS: 1US FAERS
605PhlebitisFAERS: 1US FAERS
606Pituitary enlargementFAERS: 1US FAERS
607PneumoperitoneumFAERS: 1US FAERS
608PolydipsiaFAERS: 1US FAERS
609PolyserositisFAERS: 1US FAERS
610Post-Traumatic Stress DisorderFAERS: 1US FAERS
611Preoperative CareFAERS: 1US FAERS
612Product administration errorFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
613Product container issueFAERS: 1US FAERS
614Product dosage form confusionFAERS: 1US FAERS
615Product measured potency issueFAERS: 1US FAERS
616Product storage errorFAERS: 1US FAERS
617Prothrombin time abnormalFAERS: 1US FAERS
618Pseudomonal sepsisFAERS: 1US FAERS
619Pulmonary FibrosisFAERS: 1US FAERS
620Pulmonary arterial pressure decreasedFAERS: 1US FAERS
621Pulmonary painFAERS: 1US FAERS
622Pulmonary vascular disorderFAERS: 1US FAERS
623Purulent dischargeFAERS: 1US FAERS
624PyonephrosisFAERS: 1US FAERS
625Quality of life decreasedFAERS: 1US FAERS
626RalesFAERS: 1US FAERS
627Rebound effectFAERS: 1US FAERS
628Rectal laceration postoperativeFAERS: 1US FAERS
629Rehabilitation therapyFAERS: 1US FAERS
630Respiratory tract congestionFAERS: 1US FAERS
631Respiratory tract irritationFAERS: 1US FAERS
632Restless Legs SyndromeFAERS: 1US FAERS
633RestlessnessFAERS: 1US FAERS
634RhinophymaFAERS: 1US FAERS
635Rhinovirus infectionFAERS: 1US FAERS
636Right Ventricular DysfunctionFAERS: 1US FAERS
637Right Ventricular HypertrophyFAERS: 1US FAERS
638Right ventricle outflow tract obstructionFAERS: 1US FAERS
639Rotator cuff syndromeFAERS: 1US FAERS
640SclerodactyliaFAERS: 1US FAERS
641Seizure like phenomenaFAERS: 1US FAERS
642Septic embolusFAERS: 1US FAERS
643Shunt infectionFAERS: 1US FAERS
644Sinus TachycardiaFAERS: 1US FAERS
645Skin discomfortFAERS: 1US FAERS
646Skin lesionFAERS: 1US FAERS
647SluggishnessFAERS: 1US FAERS
648Soft tissue swellingFAERS: 1US FAERS
649Spinal column injuryFAERS: 1US FAERS
650Spleen palpableFAERS: 1US FAERS
651SplenectomyFAERS: 1US FAERS
652Stem cell transplantFAERS: 1US FAERS
653Sudden infant death syndromeFAERS: 1US FAERS
654Supportive careFAERS: 1US FAERS
655Suture insertionFAERS: 1US FAERS
656Suture related complicationFAERS: 1US FAERS
657Suture ruptureFAERS: 1US FAERS
658Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
659Systemic SclerodermaFAERS: 1US FAERS
660Therapeutic product ineffectiveFAERS: 1US FAERS
661Thermal burnFAERS: 1US FAERS
662Tongue spasmFAERS: 1US FAERS
663ToothacheFAERS: 1US FAERS
664Toxicity to various agentsFAERS: 1US FAERS
665TrichorrhexisFAERS: 1US FAERS
666TrismusFAERS: 1US FAERS
667UlcerFAERS: 1US FAERS
668Umbilical herniaFAERS: 1US FAERS
669Unevaluable investigationFAERS: 1US FAERS
670Unhealthy dietFAERS: 1US FAERS
671Urinary RetentionFAERS: 1US FAERS
672Urine osmolarity increasedFAERS: 1US FAERS
673Uterine CancerFAERS: 1US FAERS
674Uterine PolypFAERS: 1US FAERS
675Uterine contractions during pregnancyFAERS: 1US FAERS
676Uterine dilation and evacuationFAERS: 1US FAERS
677Vascular Access ComplicationFAERS: 1US FAERS
678Vasculitic rashFAERS: 1US FAERS
679Vasopressive therapyFAERS: 1US FAERS
680Ventricular arrhythmiaFAERS: 1US FAERS
681Vessel perforationFAERS: 1US FAERS
682Wound closureFAERS: 1US FAERS
683Wound healing normalFAERS: 1US FAERS
684diagnostic procedureFAERS: 1US FAERS
685jaundiceFAERS: 1US FAERS
686nervous system disorderFAERS: 1US FAERS
687skin abrasionFAERS: 1US FAERS
688treatment failureFAERS: 1US FAERS
689Duodenal UlcerCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.